Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTC Erciyes University

About this trial

This prospective observational study evaluates the longitudinal changes in anhedonia levels and emotional eating behaviors among adult individuals initiating glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight loss. Participants are assessed at baseline (treatment initiation) and after a 6-month follow-up period using standardized psychometric instruments.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 years or older

Newly initiated on GLP-1 receptor agonist treatment for weight reduction

Willingness to participate in evaluations at baseline and at the 6-month follow-up

Ability to read and understand Turkish and possess the cognitive capacity to answer questionnaire items

Disqualifiers

Use of GLP-1 receptor agonists for indications other than weight loss

Cognitive, neurological, or severe psychiatric conditions preventing completion of self-report questionnaires

Substantial missing, inconsistent, or unverifiable questionnaire data compromising analysis integrity

Non-participation or dropout at the 6-month follow-up evaluation

Trial population

Adult patients attending the Erciyes University Faculty of Medicine Endocrinology and Metabolism Outpatient Clinic who are newly prescribed GLP-1 receptor agonists for weight management.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

60 Participants
are grouped into 1 trial group
Group A: GLP-1 Receptor Agonist Group

Trial outcomes

Primary outcomes

1

Change in Dimensional Anhedonia Rating Scale (DARS) Score

The DARS is a 17-item self-report questionnaire assessing state anhedonia across four domains (hobbies, food/drink, social activities, and sensory experiences). Each item is scored on a 5-point Likert scale from 0 ("Not at all") to 4 ("Extremely"), yielding a total score between 0 and 68. Lower scores indicate more severe anhedonia.

Time frame
Baseline and 6 months

Secondary outcomes

1

Change in Emotional Eating Scale (EES) Score

The Turkish version of the Emotional Eating Scale (DYÖ) consists of 10 items assessing emotional eating across 3 subscales (inability to resist eating desire, food types, and feelings of guilt). Scored on a 4-point Likert scale from 0 ("Never") to 3 ("Always"), total scores range from 0 to 30. Higher scores reflect higher levels of emotional eating behavior.

Time frame
Baseline and 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.